FDA Drug Application (202293) for FARXIGA by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number202293
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameFARXIGA
Active IngredientDAPAGLIFLOZIN PROPANEDIOL

Active IngredientCount
List of drugs with Active Ingredient DAPAGLIFLOZIN PROPANEDIOL2


Back to FDA Applications sponsored by ASTRAZENECA AB